GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Net Margin %

Biomics Biopharma (ASX:BBM) Net Margin % : 0.00% (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Biomics Biopharma's Net Income for the six months ended in . 20 was A$0.00 Mil. Biomics Biopharma's Revenue for the six months ended in . 20 was A$0.00 Mil. Therefore, Biomics Biopharma's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Biomics Biopharma's Net Margin % or its related term are showing as below:


ASX:BBM's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -150.095
* Ranked among companies with meaningful Net Margin % only.

Biomics Biopharma Net Margin % Historical Data

The historical data trend for Biomics Biopharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Net Margin % Chart

Biomics Biopharma Annual Data
Trend
Net Margin %

Biomics Biopharma Semi-Annual Data
Net Margin %

Competitive Comparison of Biomics Biopharma's Net Margin %

For the Biotechnology subindustry, Biomics Biopharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomics Biopharma's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomics Biopharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Biomics Biopharma's Net Margin % falls into.



Biomics Biopharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Biomics Biopharma's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Biomics Biopharma's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomics Biopharma  (ASX:BBM) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Biomics Biopharma Net Margin % Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines